Compare Star Bulk Carriers Corp (SBLK) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Star Bulk Carriers Corp vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? Star Bulk Carriers Corp trades at $30.36 (market cap $3.54B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.74B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 16.6× Star Bulk Carriers Corp's market cap, and Star Bulk Carriers Corp pays the higher dividend (6.17%). Which is the better fit depends on your goals — on Pluang, investors hold Star Bulk Carriers Corp for 24 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days on average.
| SBLK | TAK | |
|---|---|---|
Market Cap | $3.54B | $58.74B |
Volume | 1,437,622 | 3,110,994 |
Sector | Industrials | Health |
52-Week High | $32.49 | $19.05 |
52-Week Low | $16.79 | $13.23 |
Typical Hold Time | 24 Days | 0 Days |
Enterprise Value | $4.22B | $86.65B |
Dividend Yield | 6.17% | 3.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Star Bulk Carriers (SBLK) trades at $29.69, down 0.57% on the day, with a bearish technical signal from moving averages but neutral oscillators. Fundamentally, the company shows strong profitability with a 23.87% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights insider buying and a declared $0.90 dividend for H2 2026, reflecting management confidence.
The outlook is positive given robust earnings performance and attractive valuation multiples, though near-term technical weakness and reliance on shipping market cycles pose risks. Analyst consensus is bullish with 14 buy ratings, supporting potential upside if operational strength continues.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →
